NCT04223505Completed
Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus
Source: ClinicalTrials.gov · Last updated 12 Mar 2025
Brief summary (registry, in English)
Evaluating contrast enhanced ECG-gated cardiac CT (CCT) as an alternative to transesophageal echocardiography (TEE) to expedite cardioversion of atrial fibrillation (AF), improve patient care and reduce hospital admissions for AF and atrial flutter.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 102 (actual)
- First submitted
- 6 Jan 2020
- Start date
- 26 Jun 2020
- Primary completion date
- 21 Nov 2023
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Diseases
- Atrial fibrillation
- NCT number
- NCT04223505
What you commit to
- Study type: Interventional
- Participants enrolled: 102
- From 26 Jun 2020 to the primary completion date, 21 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Indication for acute cardioversion (e.g. hemodynamic instability, acute coronary syndrome (ACS), or pulmonary edema)
- Contraindication to TEE
- Unrepaired tracheoesophageal fistula
- Esophageal obstruction or stricture
- Perforated hollow viscus
- Poor airway control
- Severe respiratory depression
- Uncooperative, unsedated patient
Lab values
- Contraindication to Cardiac CT
- Severe renal insufficiency(GFR\< 45ml/min)
- Allergy to intravenous contrast agents
- Contraindications to radiation exposure (for example, pregnancy)
- Inability to perform 20-second breath-hold
Other
- Unwillingness or inability to provide informed consent
Who the study is looking for
- Admitted patients who require LA imaging prior to cardioversion
- Age ≥18 years old
- Able and willing to comply with the study procedures
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Ottawa Heart Institute Coordinator of this site? Confirm its status | Ottawa | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.